NCT06254495 2026-03-16A Safety Study of PF-08046044/SGN-35C in Adults With Advanced CancersSeagen Inc.Phase 1 Active not recruiting57 enrolled
NCT06870487 2026-02-19A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced CancersPfizerPhase 1 Active not recruiting6 enrolled
NCT06521567 2025-11-12A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With CancerGlaxoSmithKlinePhase 1/2 Active not recruiting83 enrolled
NCT02979522 2025-11-10A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin LymphomaTakedaPhase 1/2 Active not recruiting59 enrolled 63 charts
NCT05565417 2025-10-16Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or LymphomasImmunitas TherapeuticsPhase 1/2 Active not recruiting67 enrolled
NCT04072458 2025-02-24A Clinical Trial of BP1002 in Patients With Advanced Lymphoid MalignanciesBio-Path Holdings, Inc.Phase 1 Active not recruiting30 enrolled
NCT04268706 2023-04-05Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT)Tessa TherapeuticsPhase 2 Active not recruiting97 enrolled